Desensitization Protocol to Lenalidomide: An Effective and Safe Treatment Modality for Delayed Hypersensitivity‐induced Rash in Patients with Multiple Myeloma

Oded Shamriz,Elchanan Parnasa,Limor Rubin,Aviv Talmon,Yaarit Ribak,Eyal Lebel,Vladimir Vainstein,Shlomzion Aumann,Revital Saban,Moshe E. Gatt,Yuval Tal

European Journal of Haematology（2022）

引用 0|浏览0

暂无评分

摘要

Desensitization to lenalidomide is safe and effective. Discontinuation of lenalidomide in MM patients with delayed hypersensitivity and no contraindication to desensitization should be discouraged. Collaboration between hematologists and allergists is needed.

查看译文

关键词

delayed-type hypersensitivity,desensitization,lenalidomide,multiple myeloma,rash

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要